Showing results (51-60 of 78) with videos related to
Sort By:
Pageof 8
The American Journal of Psychiatry|September 10, 2016
Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical TrialsBret R Rutherford, Melanie M Wall, Patrick J Brown, et al.Journal of Substance Use and Addiction Treatment|September 10, 2023
Culturally tailored digital therapeutic for substance use disorders with urban Indigenous people in the United States: A randomized controlled studyAimee N C Campbell, Traci Rieckmann, Martina Pavlicova, et al.Molecular Psychiatry|June 25, 2020
Highly variable suicidal ideation: a phenotypic marker for stress induced suicide riskMaria A Oquendo, Hanga C Galfalvy, Tse-Hwei Choo, et al.Depression and Anxiety|December 24, 2016
Temporal discounting across three psychiatric disorders: Anorexia nervosa, obsessive compulsive disorder, and social anxiety disorderJoanna E Steinglass, Karolina M Lempert, Tse-Hwei Choo, et al.Journal of Substance Abuse Treatment|March 27, 2021
Association between methadone or buprenorphine use during medically supervised opioid withdrawal and extended-release injectable naltrexone induction failureMatisyahu Shulman, Tse-Hwei Choo, Jennifer Scodes, et al.Plos One|November 15, 2018
Does sex education before college protect students from sexual assault in college?John S Santelli, Stephanie A Grilo, Tse-Hwei Choo, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 13, 2023
In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behaviorElizabeth A Bartlett, Francesca Zanderigo, Barbara Stanley, et al.Journal of Substance Abuse Treatment|June 7, 2021
Naturalistic follow-up after a trial of medications for opioid use disorder: Medication status, opioid use, and relapseMiranda G Greiner, Matisyahu Shulman, Tse-Hwei Choo, et al.Journal of Addiction Medicine|August 14, 2023
Homelessness and Treatment Outcomes Among Black Adults With Opioid Use Disorder: A Secondary Analysis of X:BOTMarissa Justen, Jennifer Scodes, Martina Pavlicova, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 5, 2020
Double blind, two dose, randomized, placebo-controlled, cross-over clinical trial of the positive allosteric modulator at the alpha7 nicotinic cholinergic receptor AVL-3288 in schizophrenia patientsJoshua T Kantrowitz, Daniel C Javitt, Robert Freedman, et al.Pageof 8